Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Switzerland | Healthcare | Pharmaceuticals | CHF 712.33B | 93.6x | 1.29 | CHF 745 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Roche Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 230.81B | 27.6x | -0.99 | CHF 306.20 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.2% Downside | Upgrade to Pro+ | |
Roche Holding Participation | Switzerland | Healthcare | Pharmaceuticals | CHF 230.81B | 29.4x | -0.99 | CHF 287.70 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.2% Upside | Upgrade to Pro+ | |
Abbott Laboratories | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 201.68B | 16.8x | 0.12 | CHF 93.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novartis | Switzerland | Healthcare | Pharmaceuticals | CHF 192.99B | 18.2x | -1 | CHF 97.71 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
Novartis | Switzerland | Healthcare | Pharmaceuticals | CHF 192.99B | 18.2x | -1 | CHF 97.88 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lonza Group | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 44.27B | 58x | CHF 613 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | ||
Lonza Group | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 44.27B | 58x | CHF 613 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | ||
Alcon | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 41.34B | 38.9x | 0.25 | CHF 83.58 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.6% Upside | Upgrade to Pro+ | |
Straumann Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 20.34B | 74.9x | -2.58 | CHF 127.55 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Zimmer Biomet Holdings Inc | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 19.50B | 19.5x | 0.15 | CHF 109 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sandoz | Switzerland | Healthcare | Pharmaceuticals | CHF 19.34B | -2,379.2x | 25.94 | CHF 44.08 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.7% Downside | Upgrade to Pro+ | |
Sonova Holding | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 18.27B | -5.72 | CHF 228.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sonova H Ag | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 18.27B | 32.3x | -5.72 | CHF 306.50 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.8% Downside | Upgrade to Pro+ | |
Ypsomed Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 5.03B | 67.6x | 25.19 | CHF 368.50 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.5% Upside | Upgrade to Pro+ | |
Siegfried Holding Ltd | Switzerland | Healthcare | Pharmaceuticals | CHF 4.56B | 35.2x | -2.36 | CHF 1,062 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | |
BACHEM HOLDING AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 4.31B | 37.8x | 2.62 | CHF 57.50 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
Galenica Sante | Switzerland | Healthcare | Pharmaceuticals | CHF 4.09B | 23.1x | -0.7 | CHF 82.05 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.7% Downside | Upgrade to Pro+ | |
Dottikon Es Holding AG | Switzerland | Healthcare | Pharmaceuticals | CHF 2.94B | 39.1x | -3.23 | CHF 213 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medacta | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 2.68B | 46.2x | 3.42 | CHF 134.40 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.8% Upside | Upgrade to Pro+ | |
Joincare Pharmaceutical DRC | Switzerland | Healthcare | Pharmaceuticals | CHF 2.56B | 14.7x | 4.65 | CHF 7.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lepu Medical Tech Beijing DRC | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 2.45B | 28.8x | -0.46 | CHF 16.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 2.20B | 16.9x | 0.13 | CHF 34.95 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 2.20B | 17.4x | 0.13 | CHF 40.20 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.1% Upside | Upgrade to Pro+ | |
SKAN | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 1.76B | 55.9x | 3.07 | CHF 78.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
Aevis Victoria | Switzerland | Healthcare | Healthcare Providers & Services | CHF 1.20B | -40.8x | 0.02 | CHF 14.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSMO Pharma | Switzerland | Healthcare | Pharmaceuticals | CHF 1.02B | 15.7x | 0.03 | CHF 63.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.2% Upside | Upgrade to Pro+ | |
Medartis | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 934.01M | 222.8x | 1.49 | CHF 68.70 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kuros Biosciences | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 853.34M | -74.4x | -3.11 | CHF 22.50 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PolyPeptide Group AG | Switzerland | Healthcare | Pharmaceuticals | CHF 788.31M | -31.4x | -1.44 | CHF 23.90 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
medmix | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 513.12M | -294.9x | 2.35 | CHF 12.58 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Basilea Pharmaceutica AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 493.41M | -757.4x | 7.48 | CHF 40.70 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IVF Hartmann Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 354.86M | 20.3x | 0.61 | CHF 149 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coltene Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 329.84M | 26.8x | -0.56 | CHF 55.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.8% Upside | Upgrade to Pro+ | |
Santhera Pharmaceuticals Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 210.60M | 2.9x | 0.02 | CHF 16.72 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.7% Upside | Upgrade to Pro+ | |
Newron Pharmaceuticals | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 201.58M | -10.4x | 0.63 | CHF 10.10 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Molecular Partners AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 164.46M | -2.3x | 0.78 | CHF 4.46 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Idorsia | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 132.22M | -0.4x | -0.02 | CHF 0.70 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.8% Upside | Upgrade to Pro+ | |
Xlife Sciences | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 121.73M | 11.8x | 0.32 | CHF 21.20 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curatis Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 63.08M | -0.1x | CHF 13 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Relief Therapeutics | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 42.64M | -0.9x | -0.02 | CHF 3.40 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SHL Telemedicine | Switzerland | Healthcare | Healthcare Providers & Services | CHF 40.98M | -5.2x | 1.45 | CHF 2.50 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Addex Therapeutics Ltd | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 5.90M | 1x | -0 | CHF 0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Spexis | Switzerland | Healthcare | Pharmaceuticals | CHF 676.64K | -0.2x | CHF 0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |